Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China flag China · Delayed Price · Currency is CNY
73.50
+0.71 (0.98%)
At close: Feb 12, 2026

SHE:301033 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
330.55272.26227.54195.02153.79123.51
Other Revenue
6.186.183.330.24--
336.73278.44230.87195.25153.79123.51
Revenue Growth (YoY)
21.99%20.61%18.24%26.96%24.51%9.07%
Cost of Revenue
63.7357.6341.5831.2627.2920.82
Gross Profit
273220.81189.29163.99126.5102.69
Selling, General & Admin
129.13114.04116.17105.577359.63
Research & Development
36.2227.0926.7830.6125.8816.28
Other Operating Expenses
2.860.622.12.040.661.12
Operating Expenses
168.21141.84145.09138.2599.4977.07
Operating Income
104.7878.9744.225.7427.0125.62
Interest Expense
-0.03-0.9-2.21-1.78-0.49-
Interest & Investment Income
4.785.485.459.786.495.04
Currency Exchange Gain (Loss)
0.440.44-0.011.04-0.47-0.23
Other Non Operating Income (Expenses)
0.24-0.26-0.2-0.13-0.14-0.13
EBT Excluding Unusual Items
110.283.7247.2434.6532.430.31
Gain (Loss) on Sale of Investments
0.090.150.13-0.810.980.4
Gain (Loss) on Sale of Assets
-2.070-0.170.010.08
Asset Writedown
-0.61-0.48-0.22-1.29-0.07-0.65
Other Unusual Items
10.659.770.877.2518.2812.87
Pretax Income
118.2593.1648.0239.9651.643
Income Tax Expense
16.3414.37.144.236.926.15
Earnings From Continuing Operations
101.9178.8540.8835.7344.6836.86
Minority Interest in Earnings
---0.160.030.11
Net Income
101.9178.8540.8835.8944.7136.97
Net Income to Common
101.9178.8540.8835.8944.7136.97
Net Income Growth
49.30%92.90%13.89%-19.73%20.95%33.55%
Shares Outstanding (Basic)
666666665749
Shares Outstanding (Diluted)
666666665749
Shares Change (YoY)
1.32%-0.33%-0.80%17.43%14.83%-0.28%
EPS (Basic)
1.551.200.620.540.790.75
EPS (Diluted)
1.541.200.620.540.790.75
EPS Growth
47.36%93.55%14.82%-31.65%5.33%33.93%
Free Cash Flow
111.3283.2267.6-87.65-86.2-27.74
Free Cash Flow Per Share
1.681.271.02-1.32-1.52-0.56
Dividend Per Share
0.6000.6000.4000.2000.100-
Dividend Growth
50.00%50.00%100.00%100.00%--
Gross Margin
81.07%79.30%81.99%83.99%82.25%83.14%
Operating Margin
31.12%28.36%19.15%13.18%17.56%20.74%
Profit Margin
30.26%28.32%17.71%18.38%29.08%29.93%
Free Cash Flow Margin
33.06%29.89%29.28%-44.89%-56.05%-22.46%
EBITDA
131.15104.2868.1138.9933.1830.66
EBITDA Margin
38.95%37.45%29.50%19.97%21.57%24.82%
D&A For EBITDA
26.3725.3123.9113.256.175.04
EBIT
104.7878.9744.225.7427.0125.62
EBIT Margin
31.12%28.36%19.15%13.18%17.56%20.74%
Effective Tax Rate
13.82%15.35%14.88%10.58%13.41%14.29%
Revenue as Reported
336.73278.44230.87195.25153.79123.51
Advertising Expenses
-19.0732.5643.1223.0119.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.